纽约市COVID-19疫苗接种活动的投资回报
该决策分析模型以纽约市2020年12月14日至2022年1月31日确诊和疑似COVID-19病例校准,模拟无疫苗接种的反事实情景。结果显示,疫苗接种活动避免了279.6亿美元医疗支出和315724个潜在寿命损失年,避免统计生命价值损失262.7亿美元,净节省517.7亿美元;每投入1美元在疫苗接种上,可节省10.19美元的直接和间接健康结局成本。作者认为,这一显著投资回报支持在持续大流行期间继续投资提高疫苗接种率。
要点
- 纽约市2020年12月14日至2022年1月31日期间,疫苗接种活动避免医疗支出279.6亿美元(95% CrI,261.9亿-298.4亿)。
- 同一期间,疫苗接种活动避免315724个潜在寿命损失年(95% CrI,292143-340420),避免统计生命价值损失262.7亿美元(95% CrI,243.9亿-282.1亿)。
- 疫苗接种活动净节省517.7亿美元(95% CrI,485.0亿-558.5亿)。
- 每投入1美元在疫苗接种上,可节省10.19美元(95% CrI,9.39-10.87)的直接和间接健康结局成本。
适用人群与场景
- 纽约市2020年12月14日至2022年1月31日确诊和疑似COVID-19病例。
研究设计与关键结果
- 研究类型:决策分析模型(疾病传播模型),以纽约市2020年12月14日至2022年1月31日确诊和疑似COVID-19病例校准,并用同期观察到的住院和死亡模式验证。
- 干预与对照:实际接种疫苗的大流行轨迹与模拟的无疫苗接种反事实情景进行比较。
- 主要结局:疫苗接种活动避免医疗支出279.6亿美元(95% CrI,261.9亿-298.4亿),避免315724个潜在寿命损失年(95% CrI,292143-340420),避免统计生命价值损失262.7亿美元(95% CrI,243.9亿-282.1亿),净节省517.7亿美元(95% CrI,485.0亿-558.5亿)。
- 投资回报:每投入1美元在疫苗接种上,可节省10.19美元(95% CrI,9.39-10.87)的直接和间接健康结局成本。
- 节省来自避免的门诊就诊、急诊就诊、急救医疗服务、住院和重症监护室入院。
证据类型、等级与局限
- 证据类型:决策分析模型(模拟研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,这一显著投资回报支持在持续大流行期间继续投资提高疫苗接种率。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: New York City, an early epicenter of the pandemic, invested heavily in its COVID-19 vaccination campaign to mitigate the burden of disease outbreaks. Understanding the return on investment (ROI) of this campaign would provide insights into vaccination programs to curb future COVID-19 outbreaks.
OBJECTIVE: To estimate the ROI of the New York City COVID-19 vaccination campaign by estimating the tangible direct and indirect costs from a societal perspective.
DESIGN, SETTING, AND PARTICIPANTS: This decision analytical model of disease transmission was calibrated to confirmed and probable cases of COVID-19 in New York City between December 14, 2020, and January 31, 2022. This simulation model was validated with observed patterns of reported hospitalizations and deaths during the same period.
EXPOSURES: An agent-based counterfactual scenario without vaccination was simulated using the calibrated model.
MAIN OUTCOMES AND MEASURES: Costs of health care and deaths were estimated in the actual pandemic trajectory with vaccination and in the counterfactual scenario without vaccination. The savings achieved by vaccination, which were associated with fewer outpatient visits, emergency department visits, emergency medical services, hospitalizations, and intensive care unit admissions, were also estimated. The value of a statistical life (VSL) lost due to COVID-19 death and the productivity loss from illness were accounted for in calculating the ROI.
RESULTS: During the study period, the vaccination campaign averted an estimated $27.96 (95% credible interval [CrI], $26.19-$29.84) billion in health care expenditures and 315 724 (95% CrI, 292 143-340 420) potential years of life lost, averting VSL loss of $26.27 (95% CrI, $24.39-$28.21) billion. The estimated net savings attributable to vaccination were $51.77 (95% CrI, $48.50-$55.85) billion. Every $1 invested in vaccination yielded estimated savings of $10.19 (95% CrI, $9.39-$10.87) in direct and indirect costs of health outcomes that would have been incurred without vaccination.
CONCLUSIONS AND RELEVANCE: Results of this modeling study showed an association of the New York City COVID-19 vaccination campaign with reduction in severe outcomes and avoidance of substantial economic losses. This significant ROI supports continued investment in improving vaccine uptake during the ongoing pandemic.
参考来源
- Sah P, Vilches TN, Moghadas SM, et al. Return on Investment of the COVID-19 Vaccination Campaign in New York City. JAMA Netw Open. 2022. PMID: 36409495. doi:10.1001/jamanetworkopen.2022.43127
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。